Scholars@Duke publication: Analysis of prostate-specific antigen decline as a surrogate for overall survival in metastatic hormone-refractory prostate cancer (HRPC)

Analysis of prostate-specific antigen decline as a surrogate for overall survival in metastatic hormone-refractory prostate cancer (HRPC)

Publication , Conference

Armstrong, AJ; Eisenberger, MA; Garrett-Mayer, ES; Yang, YO; Carducci, MA; de Wit, R; Tannock, I

Published in: JOURNAL OF CLINICAL ONCOLOGY

June 20, 2007

JOURNAL OF CLINICAL ONCOLOGY

1527-7755

0732-183X

June 20, 2007

AMER SOC CLINICAL ONCOLOGY

APA

Chicago

ICMJE

MLA

NLM

Armstrong, A. J., Eisenberger, M. A., Garrett-Mayer, E. S., Yang, Y. O., Carducci, M. A., de Wit, R., & Tannock, I. (2007). Analysis of prostate-specific antigen decline as a surrogate for overall survival in metastatic hormone-refractory prostate cancer (HRPC). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 25). AMER SOC CLINICAL ONCOLOGY.

Armstrong, A. J., M. A. Eisenberger, E. S. Garrett-Mayer, Y Ou Yang, M. A. Carducci, R. de Wit, and I. Tannock. “Analysis of prostate-specific antigen decline as a surrogate for overall survival in metastatic hormone-refractory prostate cancer (HRPC).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 25. AMER SOC CLINICAL ONCOLOGY, 2007.

Armstrong AJ, Eisenberger MA, Garrett-Mayer ES, Yang YO, Carducci MA, de Wit R, et al. Analysis of prostate-specific antigen decline as a surrogate for overall survival in metastatic hormone-refractory prostate cancer (HRPC). In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2007.

Armstrong AJ, Eisenberger MA, Garrett-Mayer ES, Yang YO, Carducci MA, de Wit R, Tannock I. Analysis of prostate-specific antigen decline as a surrogate for overall survival in metastatic hormone-refractory prostate cancer (HRPC). JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2007.

JOURNAL OF CLINICAL ONCOLOGY

1527-7755

0732-183X

June 20, 2007

AMER SOC CLINICAL ONCOLOGY